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Cardiac Iodine-123 Metaiodobenzylguanidine Imaging
Predicts Sudden Cardiac Death Independently of Left
Ventricular Ejection Fraction in Patients With Chronic
Heart Failure and Left Ventricular Systolic Dysfunction
Results From a Comparative Study With Signal-Averaged
Electrocardiogram, Heart Rate Variability, and QT Dispersion
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Yusuke Iwasaki, MD,* Taku Yasui, MD,* Masatsugu Hori, MD,† Masatake Fukunami, MD*
Osaka, Japan
Objectives We prospectively compared the predictive value of cardiac iodine-123 metaiodobenzylguanidine (MIBG) imaging
for sudden cardiac death (SCD) with that of the signal-averaged electrocardiogram (SAECG), heart rate variability
(HRV), and QT dispersion in patients with chronic heart failure (CHF).
Background Cardiac MIBG imaging predicts prognosis of CHF patients. However, the long-term predictive value of MIBG imag-
ing for SCD in this population remains to be elucidated.
Methods At entry, cardiac MIBG imaging, SAECG, 24-h Holter monitoring, and standard 12-lead electrocardiography (ECG)
were performed in 106 consecutive stable CHF outpatients with a radionuclide left ventricular ejection fraction
(LVEF) 40%. The cardiac MIBG washout rate (WR) was obtained from MIBG imaging. Furthermore, the time
and frequency domain HRV parameters were calculated from 24-h Holter recordings, and QT dispersion was
measured from the 12-lead ECG.
Results During a follow-up period of 65  31 months, 18 of 106 patients died suddenly. A multivariate Cox analysis re-
vealed that WR and LVEF were significantly and independently associated with SCD, whereas the SAECG, HRV
parameters, or QT dispersion were not. Patients with an abnormal WR (27%) had a significantly higher risk of
SCD (adjusted hazard ratio: 4.79, 95% confidence interval: 1.55 to 14.76). Even when confined to the patients
with LVEF 35%, SCD was significantly more frequently observed in the patients with than without an abnormal
WR (p  0.02).
Conclusions Cardiac MIBG WR, but not SAECG, HRV, or QT dispersion, is a powerful predictor of SCD in patients with mild-to-
moderate CHF, independently of LVEF. (J Am Coll Cardiol 2009;53:426–35) © 2009 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.10.025p
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aespite advances in pharmacological treatment, mortality in
atients with chronic heart failure (CHF) remains high (1).
he 2 most common causes of death in patients with CHF
re sudden cardiac death (SCD) and pump failure. In CHF
rom the *Division of Cardiology, Osaka General Medical Center, and the †De-
artment of Cardiovascular Medicine, Osaka University Graduate School of Medi-
ine, Osaka, Japan.(
Manuscript received April 7, 2008; revised manuscript received October 20, 2008,
ccepted October 26, 2008.atients with mild-to-moderate symptoms, SCD is reported
o be the more common event (2).
To date, many efforts have been made to identify patients
t high risk for SCD, and several electrocardiographic
arkers have been proposed. In patients with CHF, sym-
athetic overactivity and parasympathetic withdrawal are
ssociated with poor outcome (3,4). Heart rate variability
HRV) is a noninvasive tool for the assessment of cardiac
utonomic regulation and has been shown to predict SCD
5,6). Furthermore, the signal-averaged electrocardiogram
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February 3, 2009:426–35 MIBG Predicts Sudden Death in HFSAECG) and QT dispersion have prognostic value in
atients with CHF (7–9). In addition, cardiac iodine-123
I-123) metaiodobenzylguanidine (MIBG) imaging, which
s useful for the estimation of cardiac adrenergic nerve
ctivity (10,11), has also been reported to predict a poor
linical outcome (12–16). However, little information is
vailable on the comparison of the prognostic value of
ardiac MIBG imaging with electrocardiographic parame-
ers such as SAECG, HRV, and QT dispersion. In this
tudy, we sought to prospectively compare the long-term
redictive value of cardiac MIBG imaging for SCD with
hat of SAECG, HRV, and QT dispersion in mild-to-
oderate CHF patients.
ethods
atients. We enrolled 106 consecutive outpatients with
HF whose radionuclide left ventricular ejection fraction
LVEF) was 40%. Chronic heart failure was diagnosed
y clinical signs and symptoms according to Framingham
riteria (17). Patients were required to be stable for at
east 3 months on conventional therapy with angiotensin-
onverting enzyme inhibitors, diuretics, and digoxin.
atients were excluded from this study if they had
linical Characteristics inhe Study Patients With and Without SCD
Table 1 Clinical Characteristics inthe Study Patients With and Without SCD
With SCD
(n  18)
Without SCD
(n  88) p Value
Age (yrs) 63 13 64 12 0.7759
Sex (male) 83% 75% 0.5544
Ischemic heart disease 56% 51% 0.7996
NYHA functional class 2.2 0.7 2.0 0.6 0.4285
Heart rate (beats/min) 73 9 74 12 0.7091
Systolic pressure (mm Hg) 126 13 128 18 0.6486
Diastolic pressure (mm Hg) 73 10 73 9 0.9015
Medications
Beta-blocker* 67% 77% 0.3729
Digitalis 67% 73% 0.7332
Diuretics 89% 78% 0.5172
ACE inhibitors 72% 70% 0.9999
Antiarrhythmic drugs (Ib/III) 28% (2/5) 24% (18/5) 0.7664
Radionuclide angiography
LVEF (%) 26 8 30 7 0.0259
Holter ECG
Lown’s grade 3.8 1.1 3.3 1.5 0.1747
VT (%) 11% 16% 0.7324
Echocardiography
LVEDD (mm) 64 5 62 8 0.3098
LAD (mm) 45 8 43 8 0.2316
Noradrenaline (pg/ml) 600 262 414 228 0.0035
Uric acid (mol/l) 445 82 397 124 0.1152
Sodium (mmol/l) 137.6 3.6 139.3 2.8 0.0637
Creatinine (mol/l) 81 29 78 21 0.6273
 106. Data are presented as the mean value  SD or percentage of patients. *Use of
eta-blocker (carvedilol), as scored at the last follow-up visit.
ACE  angiotensin-converting enzyme; LAD  left atrial dimension; LVEDD  left ventricularw
nd-diastolic dimension; LVEF  left ventricular ejection fraction; NYHA  New York Heart
ssociation; SCD  sudden cardiac death; VT  ventricular tachycardia.ignificant renal dysfunction,
nsulin-dependent diabetes
ellitus, or autonomic neurop-
thy. Patients who had been
eceiving beta-blocker drugs
ere also excluded. At the time
f enrollment, 20 and 10 pa-
ients were receiving mexiletine
nd amiodarone, respectively. At
ntry, all patients underwent car-
iac MIBG imaging, SAECG,
4-h ambulatory electrocardio-
ram (ECG) monitoring, stan-
ard 12-lead ECG, and echo-
ardiography, and a venous blood
ample was drawn. All patients
ave written, informed consent
or their participation in this study,
hich was approved by the Osaka
eneral Medical Center’s Review
ommittee.
adionuclide angiography for
ntry criteria. Before entry, pa-
ients underwent ECG-gated
lood-pool scintigraphy with a
onventional rotating gamma
amera (Prism 2000, Picker,
edford, Ohio) equipped with
low-energy, high-resolution,
arallel-hole collimator. Patients
ere given 740 MBq of tech-
etium-99m-labeled human se-
um albumin (Nihon Medi-Physics,
ishinomiya, Japan). The LVEF
as calculated with the standard
rogram (18).
ardiac MIBG imaging. No patients were taking tricyclic
ntidepressant drugs, sympathomimetic agents, or other
rugs known to interfere with MIBG uptake in the month
receding cardiac MIBG imaging.
ARDIAC MIBG ACQUISITION. All patients underwent myo-
ardial imaging with I-123 MIBG (Daiichi Radioisotope
aboratory, Tokyo, Japan) with the same gamma camera as
or the radionuclide angiography. Patients were placed in
he supine position. A 111-MBq dose of I-123 MIBG was
njected intravenously at rest after an overnight fast. Initial
nd delayed image acquisitions were performed in the
nterior chest view 20 and 200 min after the isotope
njection.
MAGE ANALYSIS. Two independent observers who were un-
ware of the clinical status of patients assessed cardiac
IBG uptake. Left ventricular activity was recorded with
manually drawn region-of-interest (ROI) over the whole
eft ventricular myocardium, and the mean heart counts/pixel
Abbreviations
and Acronyms
AUC  area under the
curve
CHF  chronic heart failure
ECG  electrocardiography/
electrocardiogram
fQRSd  the duration of
filtered QRS complex
H/M  heart-to-
mediastinum ratio
HRV  heart rate variability
LAS40  the duration of
low-amplitude signals <40
V in the terminal portion
of filtered QRS complex
LVEF  left ventricular
ejection fraction
MIBG 
metaiodobenzylguanidine
NN  normal-to-normal
NYHA  New York Heart
Association
QTc  corrected QT
interval
RMS40  the root mean
square voltage for the last
40 ms of filtered QRS
complex
ROI  region-of-interest
SAECG  signal-averaged
electrocardiogram
SCD  sudden cardiac
death
WR  washout rateere calculated. Another 7  7 pixel ROI was recorded over
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MIBG Predicts Sudden Death in HF February 3, 2009:426–35he upper mediastinal area, and the mean counts/pixel were
alculated. Background subtraction was performed with the
pper mediastinal ROI. The heart-to-mediastinum ratio
H/M) was then determined by dividing the mean counts/pixel
n the left ventricle by the mean counts/pixel in the mediasti-
um. After taking radioactive decay of I-123 into consider-
tion, the cardiac MIBG washout rate (WR) was calculated
rom the initial and delayed images, as previously reported (19).
n the basis of our previous study, abnormal WR was defined
s 27%, which was the mean control WR  2 SD (19).
AECG. In an electrically shielded room, SAECGs were
ecorded from a modified X, Y, and Z lead system by the
CM-3000 (Fukuda Denshi, Tokyo, Japan) as previously
eported (20).
The duration of filtered QRS complex (fQRSd), the root
ean square voltage for the last 40 ms of filtered QRS
omplex (RMS40), and the duration of low amplitude
ignals 40 V in the terminal portion of filtered QRS
omplex (LAS40) were measured from the vector magni-
ude by technicians that had no knowledge of the clinical
ata. Abnormal values for these 3 parameters were defined
s fQRSd130 ms, RMS4017 V, and LAS4040 ms.
late potential was defined by the presence of 2 or more
bnormal values.
4-h ambulatory ECG monitoring. Patients underwent
4-h dual-channel ambulatory ECG recording with a Mar-
uette Electronics (Milwaukee, Wisconsin) 8000 Holter
onitoring system. Recordings were analyzed by 2 inde-
Figure 1 Results of Cardiac Metaiodobenzylguanidine Imaging
Results of cardiac metaiodobenzylguanidine imaging with and without sudden card
on the delayed images; H/M(e)  heart-to-mediastinum metaiodobenzylguanidine
metaiodobenzylguanidine.endent observers who were blinded to the clinical status of hhe patients. Ventricular arrhythmias were classified accord-
ng to Lown’s grade, and nonsustained ventricular tachycar-
ia was defined as 5 or more consecutive premature ven-
ricular beats lasting 30 s.
Traditional measurements of HRV were analyzed with the
SC-3100; MemCalc/Chiram (Nihon Koden Co. Ltd., To-
yo, Japan), according to the Task Force of the European
ociety of Cardiology and the North American Society of
acing and Electrophysiology (21). Time domain analysis of
RV included the mean duration of all normal-to-normal
NN) intervals (mean RR), standard deviation of all normal-
o-normal intervals (SDNN), standard deviation of the aver-
ges of NN intervals in all 5-min segments, mean of SDNN in
ll 5-min segments (SDNN index), square root of the mean of
he sum of the squares of differences between adjacent NN
ntervals, number of NN intervals differing by more than 50 ms
rom the adjacent interval divided by the total number of NN
ntervals, and HRV triangular index. Spectral analysis was
erformed with the maximum entropy method (22). Power
pectra were quantified by the area within the following
requency band: total power (0.0001 to 0.5 Hz), ultra-low-
requency power (0.0001 to 0.003 Hz), very-low-frequency
ower (0.003 to 0.04 Hz), low-frequency power (0.04 to 0.15
z), and high-frequency power (0.15 to 0.4 Hz). The low-
requency power/high-frequency power ratio was also calcu-
ated. The power within each band was also expressed as the
ercentage of the total power (normalized ultra-low-frequency
ower, very-low-frequency power, low-frequency power, and
ath (SCD). H/M(d)  heart-to-mediastinum metaiodobenzylguanidine uptake ratio
ratio on the early images; WR  washout rate of cardiaciac de
uptakeigh-frequency power).
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February 3, 2009:426–35 MIBG Predicts Sudden Death in HFT and corrected QT interval dispersion. The QT
ntervals were measured in all 12 leads of a standard ECG.
he QT interval in each lead was calculated as the mean of
consecutive QT intervals, measuring from the beginning
f the QRS complex to the visual return of the T-wave to
he TP baseline. The QT dispersion was defined as maxi-
um minus minimum QT interval. Each QT interval was
orrected for heart rate with Bazett’s formula: QTc 
T/RR1/2(ms), where QTc is the corrected QT interval.
he QTc dispersion was determined in the same manner as
T dispersion.
chocardiography. Two-dimensional echocardiography
as performed with a Toshiba (Tokyo, Japan) SSH-380A
ecorder equipped with 2.5- or 3.75-MHz transducers.
eft ventricular end-diastolic dimension (LVEDD) and
eft atrial dimension were measured by standard tech-
easurements of the SAECG, HRV, and QTispersion i Patients With and Without SCD
Table 2 Measurements of the SAECG, HRV, and QTDispersion in Patients With and Without SCD
With SCD Without SCD p Value
SAECG (n  18) (n  88)
fQRSd (ms) 145 18 147 34 0.7604
RMS40 (V) 21 26 19 10 0.5604
LAS40 (ms) 46 19 43 18 0.5973
Late potential (%) 50% 42% 0.7684
HRV* (n  14) (n  70)
Mean RR (ms) 800 239 822 201 0.7256
SDNN (ms) 132 33 119 36 0.2352
SDANN (ms) 123 34 110 37 0.2366
SDNN index (ms) 44 17 44 13 0.9570
rMSSD (ms) 25 9 29 15 0.3139
pNN50 (%) 5.4 5.3 8.2 8.3 0.2225
HRV index 40.5 15.9 41.1 17.6 0.9073
TP (ms2) 4,946 2,557 4,571 2,572 0.6251
ULFP (ms2) 3,066 1,678 2,843 1,616 0.6460
n-ULFP (%) 61.8 8.3 62.3 11.0 0.8645
VLFP (ms2) 1,515 934 1,243 820 0.2809
n-VLFP (%) 30.0 7.9 27.5 9.2 0.3545
LFP (ms2) 250 99 259 184 0.8692
n-LFP (%) 5.6 1.9 5.8 3.0 0.7595
HFP (ms2) 100 73 150 157 0.2513
n-HFP (%) 2.3 1.3 3.3 2.6 0.1845
LFP/HFP 3.0 1.4 2.7 2.0 0.5525
QT dispersion* (n  14) (n  70)
QTd (ms) 50 26 59 24 0.2159
QTcd (ms) 53 27 65 25 0.1304
ata are presented as the mean value SD or percentage of patients. Heart rate variability (HRV)
arameters and QT dispersion were measured only in patients with sinus rhythm.
fQRSd  duration of filtered QRS complex; HFP  high-frequency power; LAS40  duration of
ow-amplitude signals 40 V; LFP  low-frequency power; Mean RR  mean duration of all
ormal-to-normal intervals; n  normalized; pNN50  number of normal-to-normal intervals
iffering by 50 ms from an adjacent interval divided by the total number of normal-to-normal
ntervals; QTcd  corrected QT interval dispersion; QTd  QT dispersion; rMSSD  square root of
he mean of the sum of squares of differences between adjacent normal-to-normal intervals;
MS40  root mean square voltage of terminal 40 ms of filtered QRS complex; SAECG 
ignal-averaged electrocardiogram; SCD  sudden cardiac death; SDANN  standard deviation of
verages of normal-to-normal intervals in all 5-min segments; SDNN  standard deviation of all
ormal-to-normal intervals; SDNN index  mean of the standard deviations of all normal-to-normal
ntervals in all 5-min segments; TP  total power; ULFP  ultra–low-frequency power; VLFP 
ery-low-frequency power.ique (23). ceasurements of plasma noradrenaline concentration
nd other parameters. Blood sampling for assessment of
he plasma noradrenaline concentration, serum uric acid,
odium, and creatinine levels was done from an intravenous
annula after resting for at least 30 min in the supine
osition. Plasma noradrenaline concentration was deter-
ined in ethylenediaminetetraacetic acid-plasma by high-
erformance liquid chromatography (24) at Shionogi
iomedical Laboratories (Osaka, Japan). A duplicate deter-
ination in the laboratory showed a coefficient of variation
f 0.4% to 5.5%.
ollow-up. All of the study patients were then followed up
rospectively in our hospital at least once a month by
linicians who were not aware of the results of cardiac
IBG imaging, SAECG, HRV, or QT dispersion. The
rimary end point of this study was SCD, defined as
itnessed cardiac arrest or death within 1 h after the onset
f acute symptoms, or unexpected, unwitnessed death in a
atient known to have been well within the previous 24 h.
ardiac death and pump failure death were the other study
nd points.
tatistical analysis. Data are presented as mean  SD.
he Student t test and Fisher exact test were used to
ompare differences in continuous and discrete variables,
espectively. In the Cox proportional hazard regression
odel, the association of the following baseline patient
haracteristics with survival was assessed: age; sex; underly-
ng causes (ischemic or nonischemic); New York Heart
ssociation (NYHA) functional class; heart rate; systolic
nd diastolic blood pressure; LVEF; presence of nonsus-
ained ventricular tachycardia on Holter monitoring; echo-
ardiography data; plasma noradrenaline concentration; se-
um uric acid, sodium, and creatinine levels; and the results
f cardiac MIBG imaging, SAECG, HRV, and QT dis-
ersion. The forward stepwise method was used for the
ultivariate analyses, with entry and removal p values set at
.05. Patients with sinus rhythm and total study patients
ere analyzed in separate models, and the results of HRV
nd QT dispersion, which cannot be measured in the
resence of atrial fibrillation, were excluded from the vari-
bles assessed in the analysis in total study patients. The
aplan-Meier method was used to calculate the event-free
urvival rate in patients with normal and abnormal WR, and
he 2 groups were compared with a log-rank test. The
iagnostic utility of WR was compared with that of LVEF
hrough the use of the receiver-operating characteristic
urves. Results are expressed in terms of the area under the
urve (AUC) and 95% confidence interval (CI) for this area.
he Fisher exact test was used to compare sensitivity,
pecificity, positive and negative predictive values, and
redictive accuracy, which meant the proportion of all test
esults—both positive and negative—that were correct
mong the different criteria for prediction of outcome.
orrelations among the various variables were evaluated
ith Spearman’s correlation coefficient. The SPSS (Chi-ago, Illinois) version 11 statistical software was used to
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MIBG Predicts Sudden Death in HF February 3, 2009:426–35nalyze the data, except for the risk-adjusted survival curves
alculated by SAS software version 9 (Cary, North Caro-
ina). A p value 0.05 was considered statistically
ignificant.
esults
atient characteristics. There were 81 men and 25 women
mean age 64  12 years). Chronic heart failure was due to
schemic heart disease in 55 patients and idiopathic dilated
ardiomyopathy in 51 patients. The average NYHA func-
ional class was 2.1  0.6, with 16% of patients in class I,
2% in class II, and 22% in class III. The radionuclide
VEF was 30  8%. Of 106 patients, 84 patients were in
inus rhythm.
ollow-up outcome. All patients were followed up com-
letely. During a mean follow-up of 65  31 months, 38
atients died. A cardiac cause was noted in 30 deaths. In
ardiac death, SCD was the most common cause (n  18),
ollowed by pump failure death (n  11) and death from
yocardial infarction (n  1).
omparison of baseline characteristics between patients
ith and without SCD. The baseline characteristics of
atients with and without SCD are listed in Table 1. There
nivariate and Multivariate Cox Proportional Hazard Analysis for thf CHF Patients at Risk of Sudden, Pump Failure, and Card ac Dea
Table 3 Univariate and Multivariate Cox Proportional Hazard Anof CHF Patients at Risk of Sudden, Pump Failure, and
Variables
Un
p Value
Cox proportional hazard model for SCD
WR 0.0006
H/M(d) 0.0020
NE 0.0045
UA 0.0193
LVEF 0.0202
H/M(e) 0.0227
Cox proportional hazard model for pump failure death
LVEDD 0.0001
WR 0.0024
LVEF 0.0036
Cr 0.0038
UA 0.0106
H/M(d) 0.0395
LAD 0.0420
Cox proportional hazard model for cardiac death
WR 0.0001
H/M(d) 0.0004
UA 0.0005
LVEF 0.0022
LVEDD 0.0025
Cr 0.0071
NE 0.0224
H/M(e) 0.0438
 106.
CI  confidence interval; Cr  serum creatinine level; H/M(d)  heart-to-mediastinum metaiod
uanidine uptake ratio on the early images; HR  hazard ratio; NE  plasma noradrenaline con
bbreviations as in Table 1.ere no differences in age, sex, the proportion of ischemic teart disease, NYHA functional class, heart rate, blood
ressure, drug use, serum uric acid, sodium and creatinine
evels, Lown’s grade, presence of nonsustained ventricular
achycardia, LVEDD, or left atrial dimension between
atients with and without SCD. Patients with SCD had a
ignificantly higher plasma concentration of noradrenaline
nd a significantly lower LVEF.
The results of cardiac MIBG imaging are shown in
igure 1. Patients with SCD had a significantly lower H/M
n the early and delayed images and a significantly higher
R than those without SCD, although there were no
ignificant differences in any of SAECG or HRV parame-
ers or QT dispersion in patients with and without SCD
Table 2).
rognostic analysis. Univariate and multivariate analysis
n total patients is shown in Table 3. In multivariate
nalysis, both WR and LVEF were the independent pre-
ictors for all end points. In addition, LVEDD and serum
reatinine level predicted pump failure death, and serum
ric acid level predicted cardiac death. The SAECG did not
redict any end points.
Sudden cardiac death, pump failure, and cardiac death-
ree survival curves adjusted for age, sex, and LVEF revealed
ntificationTotal Study Patients
is for the Identification
ac Death in Total Study Patients
e Analysis Multivariate Analysis
HR (95% CI) p Value HR (95% CI)
1.052 (1.022–1.082) 0.0014 1.052 (1.020–1.085)
0.089 (0.019–0.412) — —
1.002 (1.001–1.004) — —
1.004 (1.001–1.008) — —
0.930 (0.875–0.989) 0.0341 0.930 (0.870–0.995)
0.125 (0.021–0.747) — —
1.146 (1.069–1.230) 0.0111 1.150 (1.032–1.282)
1.067 (1.023–1.112) 0.0078 1.093 (1.024–1.167)
0.875 (0.799–0.957) 0.0219 0.865 (0.765–0.979)
1.032 (1.010–1.053) 0.0361 1.025 (1.002–1.048)
1.007 (1.002–1.013) — —
0.110 (0.013–0.900) — —
1.081 (1.003–1.166) — —
1.052 (1.029–1.076) 0.0004 1.049 (1.022–1.077)
0.125 (0.039–0.398) — —
1.005 (1.002–1.008) 0.0404 1.003 (1.000–1.007)
0.929 (0.887–0.974) 0.0018 0.920 (0.873–0.969)
1.068 (1.023–1.114) — —
1.018 (1.005–1.031) — —
1.001 (1.000–1.003) — —
0.253 (0.066–0.963) — —
guanidine uptake ratio on the delayed images; H/M(e)  heart-to-mediastinum metaiodobenzyl-
ion; UA  serum uric acid level; WR  washout rate of cardiac metaiodobenzylguanidine; othere Ideth in
alys
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obenzylhat the presence of an abnormal WR increases the risk of
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February 3, 2009:426–35 MIBG Predicts Sudden Death in HFCD by 4.79-fold, the risk of pump failure death by
.00-fold, and the risk of cardiac death by 5.64-fold in total
atients (Fig. 2).
Table 4 shows the results of the univariate and multivar-
ate Cox proportional hazard analysis for SCD, pump
ailure, and cardiac death in patients with sinus rhythm. In
ultivariate analysis, WR and LVEF were significantly
Figure 2 Adjusted Survival Curves
The SCD, pump failure, and cardiac death-free survival curves adjusted for age,
sex, and left ventricular ejection fraction in total patients with and without an
abnormal WR. CI  confidence interval; other abbreviations as in Figure 1.elated to SCD and cardiac death, whereas only LVEDD sas significantly related to pump failure death. None of the
esults of SAECG, HRV, or QT dispersion predicted any
nd points.
VEF and WR for the prediction of SCD and cardiac
eath. In total patients, the AUC with the WR used to
redict SCD was 0.715 (95% CI: 0.587 to 0.843; p 
.004), which was larger than that with LVEF (0.652, 95%
I: 0.499 to 0.806; p  0.042).
Prediction of SCD and cardiac death with LVEF and
R is shown in Table 5. Both specificity and predictive
ccuracy for abnormal WR was significantly higher than
hat for LVEF 35%. By the combination of LVEF 35%
nd abnormal WR, both indexes increased further.
elationship between the measured parameters and car-
iac MIBG imaging. In total patients, WR correlated
ositively with plasma norepinephrine levels, whereas there
as no significant correlation between H/M on the delayed
mages and plasma norepinephrine levels (Table 6).
R for the prediction of SCD in patients with LVEF
35%. Figure 3 shows SCD rates in the patients with
VEF 35% and 35% in total patients. Even when
onfined to the patients with LVEF 35%, a significantly
igher rate of SCD was observed in the patients with than
ithout abnormal WR in total patients (Fig. 4).
iscussion
he usefulness of MIBG imaging as a prognostic indicator
n CHF patients was first advocated by Merlet et al. (12)
nd has been confirmed in several studies (13–16). Addi-
ionally, cardiac MIBG imaging might be useful for pre-
icting SCD in CHF patients (13,16). However, a com-
arison of cardiac MIBG imaging with other noninvasive
arkers to predict SCD has not been performed. The
nformation about such a comparison is not available from
ur previous report (16). Therefore, we prospectively com-
ared the prognostic value of cardiac MIBG imaging with
hat of SAECG, HRV, and QT dispersion. This study
emonstrated that only cardiac MIBG imaging could pre-
ict SCD in CHF patients, whereas SAECG, HRV, or QT
ispersion did not.
omparison of prognostic value of cardiac MIBG imag-
ng with HRV. Because high sympathetic activity in CHF
atients is associated with a poor prognosis (3,4), an accurate
ssessment of cardiac sympathetic nerve activity would be of
reat importance. In the present study, cardiac MIBG imag-
ng, which provides direct information on the function and
ntegrity of the pre-synaptic sympathetic nerve endings (10,11)
nd needs only relatively low effective dose (not more than 1.5
Sv) (25), was shown to predict pump failure and cardiac
eath and, more importantly, SCD. The relationship of
ardiac MIBG and SCD would be explained by the previous
ndings that increased sympathetic activity can modulate basic
rrhythmia mechanisms of re-entry, automaticity, and trig-
ered activity to provoke lethal arrhythmias (26–28). In our
tudy, WR seemed to be superior to H/M for the prediction of
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MIBG Predicts Sudden Death in HF February 3, 2009:426–35rognosis, which is consistent with the previous report (15).
onsidering the better correlation of WR with plasma norepi-
ephrine level than that of H/M in this study, WR might
eflect the activation of the adrenergic nervous system better
han H/M.
Besides cardiac MIBG imaging, HRV is a noninvasive tool
hat allows an assessment of autonomic control of the heart (21),
nd recent studies have revealed a relationship between SCD and
nivariate and Multivariate Cox Proportional Hazard Analysis for thatients at Risk of Sudden, Pump Failure, nd C r iac Death in Pa
Table 4 Univariate and Multivariate Cox Proportional Hazard AnPatients at Risk of Sudden, Pump Failure, and Cardiac
Variables
Un
p Value
Cox proportional hazard model for SCD
WR 0.0031
LVEF 0.0148
H/M(d) 0.0169
UA 0.0448
NE 0.0498
Cox proportional hazard model for pump failure death
LVEDD 0.0008
QTd 0.0072
QTcd 0.0087
WR 0.0183
LVEF 0.0316
Cox proportional hazard model for cardiac death
WR 0.0001
H/M(d) 0.0030
LVEF 0.0070
LVEDD 0.0125
 84.
Abbreviations as in Tables 1, 2, and 3.
rediction of SCD and Cardiac Death in Patientsith Chronic Heart Failure by a Comb ation ofbnormal WR and LVEF <35% in Totaltu y P tients
Table 5
Prediction of SCD and Cardiac Death in Patients
With Chronic Heart Failure by a Combination of
Abnormal WR and LVEF <35% in Total
Study Patients
LVEF <35% Abnormal WR
LVEF <35% and
Abnormal WR
Prediction of SCD
Sensitivity (%) 83 (15/18) 78 (14/18) 61 (11/18)
Specificity (%) 30 (26/88) 56* (49/88) 67† (59/88)
Positive predictive
value (%)
19 (15/77) 26 (14/53) 28 (11/40)
Negative predictive
value (%)
90 (26/29) 92 (49/53) 89 (59/66)
Predictive accuracy (%) 39 (41/106) 59‡ (63/106) 66* (70/106)
Prediction of cardiac death
Sensitivity (%) 87 (26/30) 80 (24/30) 67 (20/30)
Specificity (%) 33 (25/76) 62* (47/76) 74† (56/76)
Positive predictive
value (%)
34 (26/77) 45 (24/53) 50 (20/40)
Negative predictive
value (%)
86 (25/29) 89 (47/53) 85 (56/66)
Predictive accuracy (%) 48 (51/106) 67‡ (71/106) 72* (76/106)
 106. The numbers in parentheses are patient numbers. *p 0.001 versus LVEF35%. †p
.0001 versus LVEF 35%. ‡p  0.01 versus LVEF 35%.
LVEF  left ventricular ejection fraction; SCD  sudden cardiac death; WR  washout rate of
ardiac metaiodobenzylguanidine. vRV (5,6). The HRV reflects the end-organ response of the
inus node to both sympathetic and parasympathetic nerve inputs,
hereas cardiac MIBG imaging “directly” reflects only sympa-
hetic nerve function, which might explain the superiority of
IBG imaging in the prediction of SCD.
AECG and QT dispersion. The SAECG identifies the
resence of slowed conduction within the myocardium, a
ubstrate for re-entrant ventricular tachycardia (29). Al-
hough the occurrence of lethal arrhythmias needs both a
ubstrate to maintain re-entry and a trigger to initiate the
rrhythmia, an abnormal SAECG reflects only the former,
hich might in part explain why SAECG failed to predict
CD in our study and previous reports (30).
ntification of CHFs With Si us Rhythm
is for the Identification of CHF
th in Patients With Sinus Rhythm
te Analysis Multivariate Analysis
HR (95% CI) p Value HR (95% CI)
1.051 (1.017–1.086) 0.0051 1.050 (1.015–1.087)
0.917 (0.856–0.983) 0.0226 0.918 (0.853–0.988)
0.103 (0.016–0.664) — —
1.006 (1.000–1.013) — —
1.002 (1.000–1.003) — —
1.205 (1.081–1.344) 0.0008 1.205 (1.081–1.344)
1.056 (1.015–1.098) — —
1.049 (1.012–1.088) — —
1.069 (1.011–1.130) — —
0.876 (0.776–0.988) — —
1.054 (1.026–1.082) 0.0001 1.057 (1.028–1.088)
0.100 (0.022–0.458) — —
0.926 (0.876–0.979) 0.0029 0.910 (0.855–0.968)
1.068 (1.014–1.124) — —
orrelation Between the Measured Parameters andhe Results of Cardiac Metaiodobenzylguanidinemaging in T tal Study Pati nts
Table 6
Correlation Between the Measured Parameters and
the Results of Cardiac Metaiodobenzylguanidine
Imaging in Total Study Patients
H/M(d) WR
Variables
Correlation
Coefficient p Value
Correlation
Coefficient p Value
Radionuclide angiography
LVEF (%) 0.078 0.4271 0.151 0.1219
Echocardiography
LVEDD (mm) 0.213 0.0298 0.249 0.0103
LAD (mm) 0.344 0.0003 0.285 0.0031
Noradrenaline (pg/ml) 0.151 0.1307 0.376 0.0001
Uric acid (mol/l) 0.18 0.0671 0.213 0.0291
Sodium (mmol/l) 0.174 0.1064 0.269 0.0109
Creatinine (mol/l) 0.212 0.0304 0.249 0.0101
 106.e Idetient
alys
Dea
ivariaLAD  left atrial dimension; LVEDD  left ventricular end-diastolic dimension; LVEF  left
entricular ejection fraction; other abbreviations as in Table 3.
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February 3, 2009:426–35 MIBG Predicts Sudden Death in HFThe QT dispersion represents the inhomogeneity of
epolarization (31), and several studies suggested QT dis-
ersion might predict SCD (8,9). However, QT dispersion
s low in reproducibility and highly dependent on the
ethod employed to measure the QT intervals. Addition-
lly, the etiology of CHF might affect the prognostic
mportance of QT dispersion (8). These might explain the
iscrepancy of our results.
omparison of prognostic value of cardiac MIBG imag-
ng with LVEF. To date, LVEF has been the most
stablished marker of the high risk of SCD in CHF
atients (32), although our results suggested that cardiac
IBG WR might be a more potent predictor of SCD
Figure 3 SCD Rates
(Left) Left ventricular ejection fraction (LVEF) 35%.
(Right) LVEF 35%. Abbreviations as in Figure 1.
Figure 4 Kaplan-Meier SCD-Free Curves
(Left) Left ventricular ejection fraction (LVEF) 35%. (Right) LVEF 35%. Abbreviahan LVEF. This discrepancy might derive from differ-
nces in patient selection and methods. However, our
ata did not deny the predictive value of LVEF for SCD,
ecause LVEF was one of the significant multivariate
redictors of SCD in both multivariate models. In
ddition, cardiac MIBG imaging was suggested to be a
owerful tool for the prediction of SCD in CHF patients
hen combined with LVEF, although the sensitivity for
CD fell substantially.
ardiac MIBG imaging for the prediction of SCD in
atients with LVEF >35%. Because there has been no
stablished method for the prediction of SCD in CHF
atients with relatively preserved LVEF (35% to 45%), our
ndings suggesting the potential usefulness of cardiac
IBG imaging even in this population has great clinical
mplication. However, a larger prospective study is needed
o address this issue, because there were only a few patients
n this population, due to our entry criteria.
oninvasive tests other than cardiac MIBG, SAECG,
RV, or QT dispersion. Of 84 patients in sinus rhythm,
eart rate turbulence and the exercise-induced change of
T dispersion, which also have been previously shown to
ave association with SCD (33,34), could be measured in 52
nd 74 patients, respectively. Although the increase in QTc
ispersion by exercise showed significant association with
CD in univariate analysis, it lost significance in multivar-
ate analysis. Moreover, we could not find any association
etween heart rate turbulence parameters and SCD. The
R independently predicted SCD in these subpopulations
s well.
tudy limitations. First, the small and empirically chosen
tudy population sample size and empirically chosen
ollow-up length are major limitations. Second, no study
atient was taking beta-blocker drugs at entry, because most
tudy patients were the participants of our placebo-
ontrolled study (T. Yamada et al., unpublished study, 1995
as in Figure 1.tions
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MIBG Predicts Sudden Death in HF February 3, 2009:426–35o 1999), where the efficacy of carvedilol or amlodipine was
nvestigated last century. The medications used during
ollow-up might affect MIBG uptake and clinical outcome.
owever, the proportion of the patients treated with beta-
locker drugs and the length of beta-blocker therapy were
ot significantly different between patients with and without
ardiac events. Third, there might have been a problem in
uantifying the cardiac MIBG images, because a large
ecrease in cardiac MIBG activity observed in CHF pa-
ients could have introduced an error when drawing the
OI manually. However, although 2 independent observers
rew the ROI in this study, the interobserver variation in
ounts/pixel was within 1.2%. Thus, errors introduced by
rawing the ROI manually on the cardiac MIBG images are
ikely to be subtle. Fourth, because we included only stable
utpatients, patients in NYHA functional class IV were not
ncluded in this study. Therefore, our results should not be
eneralized to inpatients with severe CHF. Fifth, because
his is a single-center study, one should consider a possible
thnic difference when trying to generalize our results to the
on-Japanese population. Sixth, although patients’ age is 1
f the known clinical variables associated with increased risk
f cardiac death, we could not find any association between
hem. This would be explained by the relatively young age
f our study patients and the fact that the most common
ause of cardiac death in this study was SCD, which has
een reported not to have a significant association with age
32). Lastly, failure to include data from T-wave alternans
esting, which has been recently shown to be useful for the risk
tratification of SCD in CHF patients, is a great limitation.
onclusions
o the best of our knowledge, this is the first study
omparing the predictive value of cardiac MIBG imaging
or SCD with that of SAECG, HRV, and QT dispersion in
HF patients. Cardiac MIBG WR, but not SAECG,
RV, or QT dispersion, is a powerful independent predic-
or of SCD in patients with mild-to-moderate CHF.
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